Inmune Bio (INMB) Return on Equity [ROE] (2018 - 2026)
Inmune Bio (INMB) reported Return on Equity [ROE] of -101.01% for Q2 2026, up 91.09 percentage points from -192.10% a year earlier and up 99.65 percentage points from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Inmune Bio posted Return on Equity [ROE] of -170.38%, down 47.58 percentage points from FY2024.
- Return on Equity [ROE] has declined for three consecutive years, with a five-year change of -131.16 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -122.80% in FY2024 (-61.76 pp), -61.04% in FY2023 (-24.06 pp), -36.99% in FY2022 (+12.02 pp) and -49.01% in FY2021 (-9.79 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q4 2023.
- Year over year, Return on Equity [ROE] gained in 1 of the last eight quarters, with an average year-over-year change of -41.59 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2026 (a gain of 91.09 percentage points); the low point was Q3 2025 (a drop of 78.57 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -200.66% (Q1 2026), -193.79% (Q4 2025) and -189.42% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Inmune Bio | 30.71 Mn | -50.14 Mn | - | -87.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -87.12% |
| Jun 30, 2026 | -92.41% |
| Mar 31, 2026 | -193.37% |
| Dec 31, 2025 | -188.52% |
| Sep 30, 2025 | -182.93% |
| Jun 30, 2025 | -189.81% |
| Mar 31, 2025 | -131.90% |
| Dec 31, 2024 | -118.29% |
| Sep 30, 2024 | -110.93% |
| Jun 30, 2024 | -117.02% |
| Mar 31, 2024 | -105.11% |
| Dec 31, 2023 | -74.09% |
| Sep 30, 2023 | -57.15% |
| Jun 30, 2023 | -50.22% |
| Mar 31, 2023 | -48.00% |
| Dec 31, 2022 | -45.32% |
| Sep 30, 2022 | -48.21% |
| Jun 30, 2022 | -46.13% |
| Mar 31, 2022 | -41.96% |
| Dec 31, 2021 | -36.03% |
API Access
Inmune Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();